• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

银屑病关节炎的死亡率研究:来自单一门诊诊所的结果。I. 死亡原因和风险

Mortality studies in psoriatic arthritis: results from a single outpatient clinic. I. Causes and risk of death.

作者信息

Wong K, Gladman D D, Husted J, Long J A, Farewell V T

机构信息

University of Toronto, and The Toronto Hospital, Ontario, Canada.

出版信息

Arthritis Rheum. 1997 Oct;40(10):1868-72. doi: 10.1002/art.1780401021.

DOI:10.1002/art.1780401021
PMID:9336423
Abstract

OBJECTIVE

To identify the causes of death and mortality risk in patients with psoriatic arthritis (PsA) who were being followed up at a single outpatient clinic in Toronto, Ontario, Canada.

METHODS

Patients enrolled in the PsA Clinic between 1978 and 1993 were compared with the general population of Ontario. Deaths were identified from the clinic database and through linkage with the provincial mortality database, and causes were confirmed by death certificates. A standardized mortality ratio (SMR) was computed, based on the assumption that patients lost to followup were alive at the end of the study.

RESULTS

Of the 428 patients with PsA (194 women and 234 men), 53 (26 women and 27 men) died. The 4 leading causes of death were diseases of the circulatory (36.2%) or respiratory (21.3%) system, malignant neoplasms (17.0%), and injuries/poisoning (14.9%). The SMR for the female cohort was 1.59, and for the men, it was 1.65, indicating a 59% and 65% increase in the death rate, respectively. Deaths due to respiratory causes were particularly increased in these patients.

CONCLUSION

The results suggest that this PsA Clinic outpatient population had an increased mortality risk.

摘要

目的

确定在加拿大多伦多安大略省一家门诊诊所接受随访的银屑病关节炎(PsA)患者的死亡原因和死亡风险。

方法

将1978年至1993年期间在PsA诊所登记的患者与安大略省的普通人群进行比较。通过诊所数据库并与省级死亡数据库建立联系来确定死亡情况,并通过死亡证明确认死因。基于失访患者在研究结束时仍存活的假设,计算标准化死亡率(SMR)。

结果

在428例PsA患者(194例女性和234例男性)中,53例(26例女性和27例男性)死亡。4大主要死因是循环系统疾病(36.2%)或呼吸系统疾病(21.3%)、恶性肿瘤(17.0%)以及损伤/中毒(14.9%)。女性队列的SMR为1.59,男性为1.65,分别表明死亡率增加了59%和65%。这些患者中因呼吸系统原因导致的死亡尤其增加。

结论

结果表明该PsA诊所门诊患者的死亡风险增加。

相似文献

1
Mortality studies in psoriatic arthritis: results from a single outpatient clinic. I. Causes and risk of death.银屑病关节炎的死亡率研究:来自单一门诊诊所的结果。I. 死亡原因和风险
Arthritis Rheum. 1997 Oct;40(10):1868-72. doi: 10.1002/art.1780401021.
2
Mortality studies in psoriatic arthritis: results from a single outpatient center. II. Prognostic indicators for death.银屑病关节炎的死亡率研究:来自单一门诊中心的结果。II. 死亡的预后指标。
Arthritis Rheum. 1998 Jun;41(6):1103-10. doi: 10.1002/1529-0131(199806)41:6<1103::AID-ART18>3.0.CO;2-N.
3
Improved survival in psoriatic arthritis with calendar time.银屑病关节炎患者随日历时间推移生存率提高。
Arthritis Rheum. 2007 Aug;56(8):2708-14. doi: 10.1002/art.22800.
4
Mortality in psoriatic arthritis - a single-center study from the UK.银屑病关节炎患者的死亡率——来自英国的单中心研究。
J Rheumatol. 2010 Oct;37(10):2141-4. doi: 10.3899/jrheum.100034. Epub 2010 Aug 3.
5
Mortality in psoriatic arthritis: Risk, causes of death, predictors for death.银屑病关节炎的死亡率:风险、死亡原因、死亡预测因素。
Semin Arthritis Rheum. 2020 Aug;50(4):571-575. doi: 10.1016/j.semarthrit.2020.04.001. Epub 2020 May 23.
6
Trends in mortality and cause-specific mortality among patients with psoriasis and psoriatic arthritis in Ontario, Canada.加拿大安大略省银屑病和银屑病关节炎患者的死亡率和死因特异性死亡率趋势。
J Am Acad Dermatol. 2021 May;84(5):1302-1309. doi: 10.1016/j.jaad.2020.10.031. Epub 2020 Oct 21.
7
Cause-specific mortality in patients with psoriatic arthritis and rheumatoid arthritis.银屑病关节炎和类风湿关节炎患者的特定病因死亡率。
Rheumatology (Oxford). 2017 Jun 1;56(6):907-911. doi: 10.1093/rheumatology/kew502.
8
Disease Activity and Increased Risk of Cardiovascular Death among Patients with Psoriatic Arthritis.银屑病关节炎患者的疾病活动与心血管死亡风险增加
J Rheumatol. 2016 Dec;43(12):2155-2161. doi: 10.3899/jrheum.160070. Epub 2016 Oct 1.
9
Mortality and causes of death in psoriatic arthritis.银屑病关节炎的死亡率及死亡原因
J Rheumatol Suppl. 2012 Jul;89:32-5. doi: 10.3899/jrheum.120239.
10
Reporting of mortality in a psoriatic arthritis clinic is primarily a function of the number of clinic contacts and not disease severity.银屑病关节炎诊所的死亡率报告主要取决于诊所的就诊人数,而非疾病严重程度。
J Rheumatol. 2005 Dec;32(12):2364-7.

引用本文的文献

1
Association Between Metabolic Syndrome and Radiographic Changes in Psoriatic Arthritis: A Cohort Study.代谢综合征与银屑病关节炎影像学改变之间的关联:一项队列研究。
Arthritis Care Res (Hoboken). 2025 Jul;77(7):867-872. doi: 10.1002/acr.25513. Epub 2025 Mar 22.
2
Sequential biologic therapy in the treatment of active psoriatic arthritis in China: a cost-effectiveness analysis.中国序贯生物疗法治疗活动性银屑病关节炎的成本效益分析
Clin Rheumatol. 2025 Apr;44(4):1597-1606. doi: 10.1007/s10067-025-07368-1. Epub 2025 Feb 21.
3
Pulmonary involvement in newly diagnosed and untreated rheumatoid arthritis and psoriatic arthritis: a prospective longitudinal study.
新诊断且未治疗的类风湿关节炎和银屑病关节炎的肺部受累情况:一项前瞻性纵向研究。
Rheumatol Int. 2024 Dec 18;45(1):3. doi: 10.1007/s00296-024-05751-w.
4
Cardiovascular comorbidities in psoriatic arthritis: state of the art.银屑病关节炎的心血管合并症:最新进展
Ther Adv Musculoskelet Dis. 2024 Sep 14;16:1759720X241274537. doi: 10.1177/1759720X241274537. eCollection 2024.
5
Exploring pulmonary involvement in newly diagnosed rheumatoid arthritis, and psoriatic arthritis: a single center study.探讨新诊断的类风湿关节炎和银屑病关节炎中的肺部受累:一项单中心研究。
Rheumatol Int. 2024 Oct;44(10):1975-1986. doi: 10.1007/s00296-024-05685-3. Epub 2024 Aug 21.
6
Relationship Between Ankylosing Spondylitis and Cerebrovascular Disorders: A Systematic Review.强直性脊柱炎与脑血管疾病的关系:一项系统评价
Eurasian J Med. 2024 May 9;56(2):127-35. doi: 10.5152/eurasianjmed.2024.23330.
7
The effect of guselkumab on inhibiting radiographic progression in patients with active psoriatic arthritis: study protocol for APEX, a Phase 3b, multicenter, randomized, double-blind, placebo-controlled trial.古塞单抗抑制活动性银屑病关节炎患者影像学进展的效果:APEX 研究方案,一项 3b 期、多中心、随机、双盲、安慰剂对照试验。
Trials. 2023 Jan 10;24(1):22. doi: 10.1186/s13063-022-06945-y.
8
A real-world economic analysis of biologic therapies for psoriatic arthritis in Italy: results of the CHRONOS observational longitudinal study.意大利真实世界中生物制剂治疗银屑病关节炎的经济学分析:CHRONOS 观察性纵向研究结果。
BMC Health Serv Res. 2022 Dec 16;22(1):1537. doi: 10.1186/s12913-022-08954-8.
9
Do genetics contribute to TNF inhibitor response prediction in Psoriatic Arthritis?遗传学是否有助于预测银屑病关节炎中 TNF 抑制剂的反应?
Pharmacogenomics J. 2023 Jan;23(1):1-7. doi: 10.1038/s41397-022-00290-8. Epub 2022 Oct 15.
10
Mortality in Inflammatory Rheumatic Diseases: Lithuanian National Registry Data and Systematic Review.炎症性风湿性疾病的死亡率:立陶宛国家注册数据和系统评价。
Int J Environ Res Public Health. 2021 Nov 24;18(23):12338. doi: 10.3390/ijerph182312338.